Free Trial
NASDAQ:AEZS

Aeterna Zentaris (AEZS) Stock Price, News & Analysis

Aeterna Zentaris logo
$3.29 +0.59 (+21.79%)
As of 08/22/2025

About Aeterna Zentaris Stock (NASDAQ:AEZS)

Key Stats

Today's Range
$2.55
$3.29
50-Day Range
$2.63
$4.33
52-Week Range
$3.96
$12.00
Volume
93,792 shs
Average Volume
7,305 shs
Market Capitalization
$5.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AEZS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter.

AEZS Stock News Headlines

CSCI:CA COSCIENS Biopharma Inc.
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”tc pixel
Chimerix Inc (CXF.BE)
See More Headlines

AEZS Stock Analysis - Frequently Asked Questions

Aeterna Zentaris' stock was trading at $2.77 at the start of the year. Since then, AEZS shares have increased by 18.7% and is now trading at $3.2883.

Aeterna Zentaris Inc. (NASDAQ:AEZS) announced its earnings results on Thursday, November, 4th. The biopharmaceutical company reported ($1.00) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.00) by $1.00. The biopharmaceutical company earned $0.60 million during the quarter, compared to analyst estimates of $0.60 million. Aeterna Zentaris had a negative net margin of 760.32% and a negative trailing twelve-month return on equity of 83.45%.

Aeterna Zentaris's stock reverse split on the morning of Friday, May 3rd 2024.The 1-4 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Shares of AEZS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeterna Zentaris investors own include Tonix Pharmaceuticals (TNXP), Bausch Health Cos (BHC), Ford Motor (F), DarioHealth (DRIO), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and Meta Platforms (META).

Company Calendar

Last Earnings
11/04/2021
Today
8/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AEZS
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($14.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.55 million
Net Margins
-760.32%
Pretax Margin
-760.28%
Return on Equity
-83.45%
Return on Assets
-45.76%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.94
Quick Ratio
5.93

Sales & Book Value

Annual Sales
$2.37 million
Price / Sales
2.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.99 per share
Price / Book
0.22

Miscellaneous

Outstanding Shares
1,793,000
Free Float
1,791,000
Market Cap
$5.90 million
Optionable
No Data
Beta
1.55

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:AEZS) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners